NIH Study Indicates J&J Vaccine Recipients Could Benefit From Pfizer, Moderna Boosters

The NIH released findings of a study that say recipients of the Johnson & Johnson COVID-19 vaccine may benefit from getting Pfizer or Moderna boosters as the antibody levels from those shots were seen as more robust than from a Johnson & Johnson booster.

Jun 15, 2022

More Videos

Why Home Sales Are Worse Than Ever

Gina Heeb, finance reporter at The Wall Street Journal, joins us to discuss the current state of the real estate market and when things may turn around. Watch!

How Zoom Is Getting into the Telehealth and AI Business

CEO of Suki, Punit Singh, joins Cheddar to discuss how his company is partnering with Zoom to get into the telehealth space. Watch!

Find Out What One Expert Claims 'Is My Favorite Thing Apple Has Released This Year'

Managing Editor at Tom's Guide, Kate Kozuch, joins Cheddar to explain how Apple's AirPods now work as hearing aids and what she thinks of Apple Intelligence.

Silicon Valley's View of the Presidential Election

Does the majority of Silicon Valley agree with the likes of Elon Musk? Plus, how tech companies may fare under a Trump or Harris administration. Watch!

How TikTok Star Harry Sisson Thinks Social Media Helps Presidential Campaigns

Politics influencer, Harry Sisson, joins Cheddar to discuss social media, the presidential campaign and the issue of misinformation. Watch!

How One Man Experimented With A Wholesome Side Hustle on OnlyFans

Andrew Rummer joins Cheddar to discuss his experiment setting up an OnlyFans account with more wholesome content than others. Watch!

Ingram Micro Goes Public - What to Know

Ingram Micro went public today for the second time. Chief Financial Officer, Michael Zilis joins Cheddar's Dave Briggs to discuss the public offering.

Are Influencers Taking Over The Marketing Space?

Co-founder and CEO of Rad Intel, Jeremy Barnett, joins Cheddar anchor Dave Briggs to discuss the influencer marketing space and how RAD is changing the game.

Trending Now